BCR-ABL1INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response

Tai Sung Lee*, Wanlong Ma, Xi Zhang, Maher Albitar, Francis Giles, Jorge Cortes, Hagop Kantarjian

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'BCR-ABL1<sup>INS35</sup> is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response'. Together they form a unique fingerprint.